查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1873364

病理檢測：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Pathological Examination - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球病理檢測市場預計在 2024 年達到 341.33 億美元，預計到 2031 年將達到 659.12 億美元，2025 年至 2031 年的複合年成長率為 10.0%。

病理學是一門醫學診斷學科，它透過分析組織、細胞和體液來確定疾病的性質、病因和進展。病理學涵蓋組織病理學、細胞學、免疫組織化學和分子病理學等技術。作為診斷包括癌症在內的多種疾病的黃金標準，病理學在臨床決策、手術計劃制定和預後評估中發揮著至關重要的作用。

病理檢測市場的發展主要受全球癌症和其他慢性疾病發生率上升的驅動，這些疾病都需要基於組織的診斷。隨著醫療保健系統向精準醫療轉型，對組織病理學、細胞學和分子病理學等精準的早期診斷工具的需求持續成長。數位病理學、免疫組織化學 (IHC) 和次世代定序(NGS) 等技術的進步，拓展了病理學的應用範圍，使其超越了傳統的顯微鏡檢查，從而提高了工作流程效率、診斷準確性，並實現了個性化治療策略。

儘管病理檢測市場具有巨大的成長潛力，但仍面臨許多挑戰，包括訓練有素的病理學家短缺，尤其是在開發中國家。傳統病理的手動工作流程耗時且容易出錯。此外，採用數位化病理需要大量的基礎性投資、標準化以及監管核准。而且，組織樣本品質的差異、複雜的報銷環境以及與醫院資訊系統（HIS/LIS）的整合難題，都持續阻礙先進病理技術的廣泛應用。

本報告旨在對全球病理檢測市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名，並按地區/國家、類型和應用對病理檢測進行分析。

本報告以銷售收入為指標，對病理檢測市場規模、估算和預測進行了呈現，以2024年為基準年，並包含了2020年至2031年的歷史數據和預測數據。報告運用定量和定性分析相結合的方法，幫助讀者制定業務/成長策略，評估市場競爭格局，分析公司在當前市場中的地位，並就病理檢測做出明智的商業決策。

市場區隔

公司

  • Quest Diagnostics
  • Sonic Healthcare
  • Lab Corp
  • Unilabs
  • SYNLAB International
  • BML
  • Pathologists Diagnostic
  • StageBio
  • KingMed Diagnostics Group
  • Dian Diagnostics Group
  • Adicon Clinical Laboratories Inc.
  • Huayin Health

按類型分類的細分市場

  • 組織病理學
  • 細胞病理學
  • 免疫組織化學病理學
  • 分子病理學

應用領域

  • 醫院
  • 臨床檢查室

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Pathological Examination was estimated to be worth US$ 34133 million in 2024 and is forecast to a readjusted size of US$ 65912 million by 2031 with a CAGR of 10.0% during the forecast period 2025-2031.

Pathological examination is a medical diagnostic process that involves the analysis of tissues, cells, or bodily fluids to determine the nature, cause, and extent of disease. It includes techniques such as histopathology, cytology, immunohistochemistry, and molecular pathology. As the gold standard for diagnosing cancers and many other diseases, pathological examination plays a critical role in clinical decision-making, surgical planning, and prognosis assessment.

The pathological examination market is driven by the increasing global incidence of cancer and other chronic diseases that require tissue-based diagnosis. As healthcare systems shift toward precision medicine, the demand for accurate, early-stage diagnostic tools such as histopathology, cytology, and molecular pathology continues to rise. Technological advancements-such as digital pathology, immunohistochemistry (IHC), and next-generation sequencing (NGS)-have expanded the scope of pathology beyond traditional microscopy, improving workflow efficiency, diagnostic accuracy, and enabling personalized treatment strategies.

Despite strong growth potential, the pathological examination market faces key challenges including a shortage of trained pathologists, especially in developing countries. Manual workflow in traditional pathology can be time-consuming and error-prone, and digital pathology implementation requires significant infrastructure investment, standardization, and regulatory approval. Furthermore, variability in tissue sample quality, complex reimbursement environments, and integration issues with hospital information systems (HIS/LIS) continue to pose barriers to the widespread adoption of advanced pathology technologies.

This report aims to provide a comprehensive presentation of the global market for Pathological Examination, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pathological Examination by region & country, by Type, and by Application.

The Pathological Examination market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pathological Examination.

Market Segmentation

By Company

  • Quest Diagnostics
  • Sonic Healthcare
  • Lab Corp
  • Unilabs
  • SYNLAB International
  • BML
  • Pathologists Diagnostic
  • StageBio
  • KingMed Diagnostics Group
  • Dian Diagnostics Group
  • Adicon Clinical Laboratories Inc.
  • Huayin Health

Segment by Type

  • Histopathology
  • Cytopathology
  • Immunohistochemical Pathology
  • Molecular Pathology

Segment by Application

  • Hospital
  • Medical Laboratory

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Pathological Examination company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Pathological Examination in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Pathological Examination in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Pathological Examination Product Introduction
  • 1.2 Global Pathological Examination Market Size Forecast (2020-2031)
  • 1.3 Pathological Examination Market Trends & Drivers
    • 1.3.1 Pathological Examination Industry Trends
    • 1.3.2 Pathological Examination Market Drivers & Opportunity
    • 1.3.3 Pathological Examination Market Challenges
    • 1.3.4 Pathological Examination Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Pathological Examination Players Revenue Ranking (2024)
  • 2.2 Global Pathological Examination Revenue by Company (2020-2025)
  • 2.3 Key Companies Pathological Examination Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Pathological Examination Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Pathological Examination
  • 2.6 Pathological Examination Market Competitive Analysis
    • 2.6.1 Pathological Examination Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Pathological Examination Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pathological Examination as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Histopathology
    • 3.1.2 Cytopathology
    • 3.1.3 Immunohistochemical Pathology
    • 3.1.4 Molecular Pathology
  • 3.2 Global Pathological Examination Sales Value by Type
    • 3.2.1 Global Pathological Examination Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Pathological Examination Sales Value, by Type (2020-2031)
    • 3.2.3 Global Pathological Examination Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Medical Laboratory
  • 4.2 Global Pathological Examination Sales Value by Application
    • 4.2.1 Global Pathological Examination Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Pathological Examination Sales Value, by Application (2020-2031)
    • 4.2.3 Global Pathological Examination Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Pathological Examination Sales Value by Region
    • 5.1.1 Global Pathological Examination Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Pathological Examination Sales Value by Region (2020-2025)
    • 5.1.3 Global Pathological Examination Sales Value by Region (2026-2031)
    • 5.1.4 Global Pathological Examination Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Pathological Examination Sales Value, 2020-2031
    • 5.2.2 North America Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Pathological Examination Sales Value, 2020-2031
    • 5.3.2 Europe Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Pathological Examination Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Pathological Examination Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Pathological Examination Sales Value, 2020-2031
    • 5.5.2 South America Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Pathological Examination Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Pathological Examination Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Pathological Examination Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Pathological Examination Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Pathological Examination Sales Value, 2020-2031
    • 6.3.2 United States Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Pathological Examination Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Pathological Examination Sales Value, 2020-2031
    • 6.4.2 Europe Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Pathological Examination Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Pathological Examination Sales Value, 2020-2031
    • 6.5.2 China Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Pathological Examination Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Pathological Examination Sales Value, 2020-2031
    • 6.6.2 Japan Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Pathological Examination Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Pathological Examination Sales Value, 2020-2031
    • 6.7.2 South Korea Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Pathological Examination Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Pathological Examination Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Pathological Examination Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Pathological Examination Sales Value, 2020-2031
    • 6.9.2 India Pathological Examination Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Pathological Examination Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Quest Diagnostics
    • 7.1.1 Quest Diagnostics Profile
    • 7.1.2 Quest Diagnostics Main Business
    • 7.1.3 Quest Diagnostics Pathological Examination Products, Services and Solutions
    • 7.1.4 Quest Diagnostics Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Quest Diagnostics Recent Developments
  • 7.2 Sonic Healthcare
    • 7.2.1 Sonic Healthcare Profile
    • 7.2.2 Sonic Healthcare Main Business
    • 7.2.3 Sonic Healthcare Pathological Examination Products, Services and Solutions
    • 7.2.4 Sonic Healthcare Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Sonic Healthcare Recent Developments
  • 7.3 Lab Corp
    • 7.3.1 Lab Corp Profile
    • 7.3.2 Lab Corp Main Business
    • 7.3.3 Lab Corp Pathological Examination Products, Services and Solutions
    • 7.3.4 Lab Corp Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Lab Corp Recent Developments
  • 7.4 Unilabs
    • 7.4.1 Unilabs Profile
    • 7.4.2 Unilabs Main Business
    • 7.4.3 Unilabs Pathological Examination Products, Services and Solutions
    • 7.4.4 Unilabs Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Unilabs Recent Developments
  • 7.5 SYNLAB International
    • 7.5.1 SYNLAB International Profile
    • 7.5.2 SYNLAB International Main Business
    • 7.5.3 SYNLAB International Pathological Examination Products, Services and Solutions
    • 7.5.4 SYNLAB International Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.5.5 SYNLAB International Recent Developments
  • 7.6 BML
    • 7.6.1 BML Profile
    • 7.6.2 BML Main Business
    • 7.6.3 BML Pathological Examination Products, Services and Solutions
    • 7.6.4 BML Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.6.5 BML Recent Developments
  • 7.7 Pathologists Diagnostic
    • 7.7.1 Pathologists Diagnostic Profile
    • 7.7.2 Pathologists Diagnostic Main Business
    • 7.7.3 Pathologists Diagnostic Pathological Examination Products, Services and Solutions
    • 7.7.4 Pathologists Diagnostic Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Pathologists Diagnostic Recent Developments
  • 7.8 StageBio
    • 7.8.1 StageBio Profile
    • 7.8.2 StageBio Main Business
    • 7.8.3 StageBio Pathological Examination Products, Services and Solutions
    • 7.8.4 StageBio Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.8.5 StageBio Recent Developments
  • 7.9 KingMed Diagnostics Group
    • 7.9.1 KingMed Diagnostics Group Profile
    • 7.9.2 KingMed Diagnostics Group Main Business
    • 7.9.3 KingMed Diagnostics Group Pathological Examination Products, Services and Solutions
    • 7.9.4 KingMed Diagnostics Group Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.9.5 KingMed Diagnostics Group Recent Developments
  • 7.10 Dian Diagnostics Group
    • 7.10.1 Dian Diagnostics Group Profile
    • 7.10.2 Dian Diagnostics Group Main Business
    • 7.10.3 Dian Diagnostics Group Pathological Examination Products, Services and Solutions
    • 7.10.4 Dian Diagnostics Group Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Dian Diagnostics Group Recent Developments
  • 7.11 Adicon Clinical Laboratories Inc.
    • 7.11.1 Adicon Clinical Laboratories Inc. Profile
    • 7.11.2 Adicon Clinical Laboratories Inc. Main Business
    • 7.11.3 Adicon Clinical Laboratories Inc. Pathological Examination Products, Services and Solutions
    • 7.11.4 Adicon Clinical Laboratories Inc. Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Adicon Clinical Laboratories Inc. Recent Developments
  • 7.12 Huayin Health
    • 7.12.1 Huayin Health Profile
    • 7.12.2 Huayin Health Main Business
    • 7.12.3 Huayin Health Pathological Examination Products, Services and Solutions
    • 7.12.4 Huayin Health Pathological Examination Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Huayin Health Recent Developments

8 Industry Chain Analysis

  • 8.1 Pathological Examination Industrial Chain
  • 8.2 Pathological Examination Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Pathological Examination Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Pathological Examination Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Pathological Examination Market Trends
  • Table 2. Pathological Examination Market Drivers & Opportunity
  • Table 3. Pathological Examination Market Challenges
  • Table 4. Pathological Examination Market Restraints
  • Table 5. Global Pathological Examination Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Pathological Examination Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Pathological Examination Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Pathological Examination Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Pathological Examination
  • Table 10. Global Pathological Examination Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pathological Examination as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Pathological Examination Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Pathological Examination Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Pathological Examination Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Pathological Examination Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Pathological Examination Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Pathological Examination Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Pathological Examination Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Pathological Examination Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Pathological Examination Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Pathological Examination Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Pathological Examination Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Pathological Examination Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Pathological Examination Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Pathological Examination Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Pathological Examination Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Pathological Examination Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Pathological Examination Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Pathological Examination Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Quest Diagnostics Basic Information List
  • Table 32. Quest Diagnostics Description and Business Overview
  • Table 33. Quest Diagnostics Pathological Examination Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Pathological Examination Business of Quest Diagnostics (2020-2025)
  • Table 35. Quest Diagnostics Recent Developments
  • Table 36. Sonic Healthcare Basic Information List
  • Table 37. Sonic Healthcare Description and Business Overview
  • Table 38. Sonic Healthcare Pathological Examination Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Pathological Examination Business of Sonic Healthcare (2020-2025)
  • Table 40. Sonic Healthcare Recent Developments
  • Table 41. Lab Corp Basic Information List
  • Table 42. Lab Corp Description and Business Overview
  • Table 43. Lab Corp Pathological Examination Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Pathological Examination Business of Lab Corp (2020-2025)
  • Table 45. Lab Corp Recent Developments
  • Table 46. Unilabs Basic Information List
  • Table 47. Unilabs Description and Business Overview
  • Table 48. Unilabs Pathological Examination Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Pathological Examination Business of Unilabs (2020-2025)
  • Table 50. Unilabs Recent Developments
  • Table 51. SYNLAB International Basic Information List
  • Table 52. SYNLAB International Description and Business Overview
  • Table 53. SYNLAB International Pathological Examination Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Pathological Examination Business of SYNLAB International (2020-2025)
  • Table 55. SYNLAB International Recent Developments
  • Table 56. BML Basic Information List
  • Table 57. BML Description and Business Overview
  • Table 58. BML Pathological Examination Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Pathological Examination Business of BML (2020-2025)
  • Table 60. BML Recent Developments
  • Table 61. Pathologists Diagnostic Basic Information List
  • Table 62. Pathologists Diagnostic Description and Business Overview
  • Table 63. Pathologists Diagnostic Pathological Examination Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Pathological Examination Business of Pathologists Diagnostic (2020-2025)
  • Table 65. Pathologists Diagnostic Recent Developments
  • Table 66. StageBio Basic Information List
  • Table 67. StageBio Description and Business Overview
  • Table 68. StageBio Pathological Examination Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Pathological Examination Business of StageBio (2020-2025)
  • Table 70. StageBio Recent Developments
  • Table 71. KingMed Diagnostics Group Basic Information List
  • Table 72. KingMed Diagnostics Group Description and Business Overview
  • Table 73. KingMed Diagnostics Group Pathological Examination Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Pathological Examination Business of KingMed Diagnostics Group (2020-2025)
  • Table 75. KingMed Diagnostics Group Recent Developments
  • Table 76. Dian Diagnostics Group Basic Information List
  • Table 77. Dian Diagnostics Group Description and Business Overview
  • Table 78. Dian Diagnostics Group Pathological Examination Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Pathological Examination Business of Dian Diagnostics Group (2020-2025)
  • Table 80. Dian Diagnostics Group Recent Developments
  • Table 81. Adicon Clinical Laboratories Inc. Basic Information List
  • Table 82. Adicon Clinical Laboratories Inc. Description and Business Overview
  • Table 83. Adicon Clinical Laboratories Inc. Pathological Examination Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Pathological Examination Business of Adicon Clinical Laboratories Inc. (2020-2025)
  • Table 85. Adicon Clinical Laboratories Inc. Recent Developments
  • Table 86. Huayin Health Basic Information List
  • Table 87. Huayin Health Description and Business Overview
  • Table 88. Huayin Health Pathological Examination Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Pathological Examination Business of Huayin Health (2020-2025)
  • Table 90. Huayin Health Recent Developments
  • Table 91. Key Raw Materials Lists
  • Table 92. Raw Materials Key Suppliers Lists
  • Table 93. Pathological Examination Downstream Customers
  • Table 94. Pathological Examination Distributors List
  • Table 95. Research Programs/Design for This Report
  • Table 96. Key Data Information from Secondary Sources
  • Table 97. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Pathological Examination Product Picture
  • Figure 2. Global Pathological Examination Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Pathological Examination Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Pathological Examination Report Years Considered
  • Figure 5. Global Pathological Examination Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Pathological Examination Revenue in 2024
  • Figure 7. Pathological Examination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Histopathology Picture
  • Figure 9. Cytopathology Picture
  • Figure 10. Immunohistochemical Pathology Picture
  • Figure 11. Molecular Pathology Picture
  • Figure 12. Global Pathological Examination Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 13. Global Pathological Examination Sales Value Market Share by Type, 2024 & 2031
  • Figure 14. Product Picture of Hospital
  • Figure 15. Product Picture of Medical Laboratory
  • Figure 16. Global Pathological Examination Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 17. Global Pathological Examination Sales Value Market Share by Application, 2024 & 2031
  • Figure 18. North America Pathological Examination Sales Value (2020-2031) & (US$ Million)
  • Figure 19. North America Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • Figure 20. Europe Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 21. Europe Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Asia Pacific Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Asia Pacific Pathological Examination Sales Value by Region (%), 2024 VS 2031
  • Figure 24. South America Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. South America Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • Figure 26. Middle East & Africa Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. Middle East & Africa Pathological Examination Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Key Countries/Regions Pathological Examination Sales Value (%), (2020-2031)
  • Figure 29. United States Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. United States Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 31. United States Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 32. Europe Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Europe Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 34. Europe Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 35. China Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. China Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 37. China Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 38. Japan Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. Japan Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 40. Japan Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 41. South Korea Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. South Korea Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 43. South Korea Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 44. Southeast Asia Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. Southeast Asia Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 46. Southeast Asia Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 47. India Pathological Examination Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. India Pathological Examination Sales Value by Type (%), 2024 VS 2031
  • Figure 49. India Pathological Examination Sales Value by Application (%), 2024 VS 2031
  • Figure 50. Pathological Examination Industrial Chain
  • Figure 51. Pathological Examination Manufacturing Cost Structure
  • Figure 52. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 53. Bottom-up and Top-down Approaches for This Report
  • Figure 54. Data Triangulation
  • Figure 55. Key Executives Interviewed